Cardiac Valvular Medicine

Herausgegeben:Rajamannan, Nalini M.

• Gebundenes Buch

Produktbeschreibung

The book will be written by the experts in the disease including imaging, interventional cardiology and surgical valve expertise. The book has five main sections:Aortic Valve DiseaseMitral Valve DiseaseTricuspid Valve DiseasePulmonic Valve DiseaseMultimodality ImagingThe main objectives of the book are:1- to provide the main guidelines to clinicians on how to identify and diagnose valvular heart disease2- to provide an overview of what the near future will bring in the diagnosis, prevention and risk stratification of patients to catheter versus surgical approaches3- to outline the possible implications for medical therapies in slowing progression of calcific aortic valve disease and myxomatous mitral valve disease

Produktdetails

• Verlag: Springer / Springer London / Springer, Berlin
• Artikelnr. des Verlages: 978-1-4471-4131-0
• 2013
• Seitenzahl: 268
• Erscheinungstermin: 14. September 2012
• Englisch
• Abmessung: 260mm x 183mm x 20mm
• Gewicht: 744g
• ISBN-13: 9781447141310
• ISBN-10: 1447141318
• Artikelnr.: 36275424

Autorenporträt

Nalini M. Rajamannan

Inhaltsangabe

1.Natural History of Aortic Valve Stenosis.- 2. Cardiovascular Risk Factors for Calcific Aortic Valve Disease.- 3.Bicuspid Aortic Valve Disease: From Bench to Bedside.- 4.Experimental Evidence for the Role of Atherosclerosis in Calcific Aortic Valve Disease.- 5.The Electrocardiogram as a Risk Predictor in Asymptomatic Aortic Stenosis.- 6.Exercise Testing in Aortic Stenosis and in Mitral Regurgitation.- 7. Detection of Calcium in the Aortic Valve by Non- Invasive Imaging.- 8.Assessment of Aortic Stenosis Severity:Determining Timing to Surgery.- 9.Balloon Aortic Valvuloplasty.- 10.Imaging for TAVI.- 11.Transcutaneous Aortic Valve Implantation.- 12.Role of statins in valvular heart disease: Rheumatic valve disease and bioprosthetic valves.- 13.Slowing the Progression of Aortic Stenosis - The Emerging Role of Bisphosphonates.- 14.LDL-Density-Theory:Implications for Future Clinical Trials.- 15.Infective Endocarditis: New Recommendations and Perspectives.- 16.Assessment and Timing to Intervention of Mitral Regurgitation.- 17. Biology of Mitral Valve Disease.- 18.Mitral Valve Devices.- 19.Anatomy and Pathology of Right-sided atrioventricular and semilunal valves.- 20.Mechanisms, Evaluation and Management of Tricuspid Regurgitation

---

1.Natural History of Aortic Valve Stenosis.- 2. Cardiovascular Risk Factors for Calcific Aortic Valve Disease.- 3.Bicuspid Aortic Valve Disease: From Bench to Bedside.- 4.Experimental Evidence for the Role of Atherosclerosis in Calcific Aortic Valve Disease.- 5.The Electrocardiogram as a Risk Predictor in Asymptomatic Aortic Stenosis.- 6.Exercise Testing in Aortic Stenosis and in Mitral Regurgitation.- 7. Detection of Calcium in the Aortic Valve by Non- Invasive Imaging.- 8.Assessment of Aortic Stenosis Severity:Determining Timing to Surgery.- 9.Balloon Aortic Valvuloplasty.- 10.Imaging for TAVI.- 11.Transcutaneous Aortic Valve Implantation.- 12.Role of statins in valvular heart disease: Rheumatic valve disease and bioprosthetic valves.- 13.Slowing the Progression of Aortic Stenosis – The Emerging Role of Bisphosphonates.- 14.LDL-Density-Theory:Implications for Future Clinical Trials.- 15.Infective Endocarditis: New Recommendations and Perspectives.- 16.Assessment and Timing to Intervention of Mitral Regurgitation.- 17. Biology of Mitral Valve Disease.- 18.Mitral Valve Devices.- 19.Anatomy and Pathology of Right-sided atrioventricular and semilunal valves.- 20.Mechanisms, Evaluation and Management of Tricuspid Regurgitation